As the T24 cell line contains the mutant p53, while the EJ cell line expresses the wild-type p53, the results suggested that circNUDT21 may exert its oncogenic function through the MDM2-p53 pathway in bladder cancer, regardless of the p53 mutation status. The gene discussed is TP53; the disease is urinary bladder cancer.